Article
Modulating hepatic stellate cell senescence: A promising therapeutic strategy for liver fibrosis.
Hepatobiliary & pancreatic diseases international : HBPD INT - 1 Aug 2026
Sharmila Muthusethupathi, Shree Harini Karthik, Ezhilarasan Devaraj
Abstract excerpt
Fibrosis is characterized by the abnormal deposition of extracellular matrix (ECM) components in liver tissue following chronic liver injury, ultimately leading to hepatic cirrhosis. Following liver damage, hepatic stellate cells (HSCs) undergo transition from a quiescent to an activated phenotype which differentiate into proliferative, fibrogenic, and contractile myofibroblasts. The activated HSCs act as the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
